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Abstract  
 Background: hypertension affects many people worldwide and it is 
highly prevalent in Jordan. Living at different areas with different attitudes 
may  have impacts in hypertension. 
Study objectives: to identify the prevalence of hypertension in two areas in 
Jordan with different attitudes and to determine the impact of attitudes in 
hypertension and angiotensin II to be able to determine the appropriate 
antihypertensive drug for such population. 
Methodology: a cross-sectional study design was conducted to collect data 
from participants. The study included 1000 participants, 500 from each area. 
A constructed questionnaire was used in this study. Blood samples were taken 
from participants to assay for angiotensin II. Blood pressure was measured for 
all patients. Data was analyzed using SPSS version 20. Data was presented as 
means, frequencies, percentages. The relationship between variables was 
examined using independent T-test. Significance was considered at alpha level 
<0.05.  
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Study findings: the main findings of the present study were that cardiac 
variables including SPS, DBP, MBP, and pulse were significantly higher in 
Ajloun compared with the Sea level area (p=0.001). This is also applied for 
PCV. The mean concentration of angiotensin II in the Sea level was 11.21± 
6.05 pg/ml, and this was lower than that in the Ajloun area 12.08± 5.19, but 
this mean difference was not statistically significant (p>0.05). 
Conclusions: living in high altitude is associated with increased potential to 
have increased levels of cardiac parameters independently of the level of 
angiotensin II and the therapeutic options for patients with hypertension 
should be taken into account. 
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Introduction 
In this study, there is an interest in exploring cardiac parameters among 
participants living in two areas with different altitudes. In Jordan, there is a 
diversity in environmental components including variations in altitudes. 
Hypertension is considered as a significant cause of the total disease 
burden globally (Lim et al., 2012). Several studies have shown that 
hypertension is highly associated with cardiovascular diseases including 
stroke and ischemic heart disease (Stokes et al., 1989; Eckner, 2014).  
Hypertension is considered as a bad predictor of heart disease (CDC, 
2015). It has been estimated that about 67 million Americans are with high 
blood pressure among which are 36% have uncontrolled high blood pressure 
(Delacroix et al., 2014). The global prevalence of hypertension has been 
estimated to be 40% (Nwankwo et al., 2012).  
It has been reported that both treatment and awareness of high blood 
pressure were not enough and this was demonstrated by the law of halves 
which means that only half of hypertensive patients were aware of their 
disease, and only half of them were treated, and of those who were treated 
achieved treatment goals (Eckner, 2014). Although the treatment of 
hypertension has lowered the events of cardiovascular system, but it is still 
believed that high blood pressure and hypertension can be improved further 
(Lindblad et al., 2011).   
The present study is the first in Jordan to assess the level of 
hypertension parameters in different areas according to their altitudes. 
Accordingly, the objectives of the present study were to identify the 
prevalence of hypertension in two areas in Jordan with different attitudes and 
to determine the impact of attitudes in hypertension and angiotensin II to be 
able to determine the appropriate antihypertensive drug for such population.  
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Methods and subjects 
Study design: we conducted a cross sectional study to collect data from 
study participants within the same time frame. 
Study setting 
We conducted our study in two areas with different altitudes: the Sea 
level area and Ajloun area, Jordan. 
Study sample  
A total of 1000 participants were included in this study. Of them, 
500 participants were included from each area. All participants were males, 
matched for age grouping, and they were apparently healthy. 
Data collection  
We collected and tabulated the data for each participant. The 
variables under investigation included blood pressure, weight, height, waist 
circumference, heart rate per minute, the level of angiotensin II, and  packed 
cell volume (PCV). 
Data analysis 
We depended on SPSS version 20 to analyze the data. Data were 
represented as mean and standard deviation. The relations between variables 
were computed using independent T test. Significance was considered at alpha 
<0.05. 
 
Results  
Comparison between the Means and Standard Deviations of Blood 
Pressure and other Variables in the Sea Level and Ajloun 
The data presented in table 1 showed the mean differences for some 
variables among participants in the two different study areas with different 
altitudes, Ajloun and the Sea level. Similar patterns of frequency were 
observed for the following variables: age, weight, height, BMI, and waist 
circumferences, and accordingly no significant differences were observed 
(p>0.05). On the other hand, it was interestingly found that all cardiac 
variables including SPS, DBP, MBP, and pulse were significantly higher in 
Ajloun compared with the Sea level area (p=0.001). This is also applied for 
PCV.  
Table 1: Comparison between the Means and Standard Deviations of Blood Pressure and 
other Variables in the Sea Level and Ajloun. 
P value Ajloun Sea level  
Mean ± std Mean ± std Variables 
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NS 17.83 ± 0.69 17.60  ± 0.51 Age 
NS 67.37 ±10.76 67.69  ±  8.70 Weight/kg 
NS 169.51±7.42 170.50±  5.85 Height/cm 
NS 23.42 ± 3.22 23.26  ±  2.57 BMI 
NS 75.99 ±10.21 76.38  ± 6.00 Waist cir./cm 
0.001 125.74±10.01 118.07±11.64 SBP/mmHg 
0.001 79.62  ± 8.43 75.74  ± 8.48 DBP/mmHg 
0.001 94.95 ± 8.03 89.84  ± 8.72 MBP/mmHg 
0.001 81.71 ± 5.66 79.07  ± 6.46 Pulse/minute 
0.001 45.27 ± 2.18 41.50  ± 3.27 PCV 
 
Comparison between Angiotensin II Concentration in Ajloun and the Sea 
level Areas 
As seen in table 2 and figure 1, the mean concentration of angiotensin 
II in the Sea level was 11.21± 6.05 pg/ml, and this was lower than that in the 
Ajloun area 12.08± 5.19, but this mean difference was not statistically 
significant (p>0.05).  
Table 2: Comparison between Angiotensin II Concentration in Ajloun and the Sea level 
Areas 
 
 
Figure 1: the angiotensin level in the Sea level and Ajloun 
Discussion 
The results of the present study did not show that the mean of heart 
readings pointed to hypertension in both study areas the Sea level and Ajloun. 
We think this may due to two factors: young age relatively at both areas and 
participants were chosen to be apparently healthy. Accordingly, our results are 
Series1; The Sea 
level; 11,21
Series1; Ajloun; 
12,08
P value Mean ± std Target Area Mean ± std Target Area 
NS 12.08 ± 5.19 Ajloun 11.21± 6.05 Sea level 
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good to indicate the physiological status of heart parameters and to investigate 
the effect of altitude on these parameters. 
The findings of our study indicated that heart parameters relating to 
hypertension including SPS, DBP, MBP, and pulse were significantly higher 
in Ajloun compared with the Sea level area (p=0.001). This is also applied for 
PCV. Actually, these findings reflected the effects of altitude on blood 
pressure. These findings are in line with other studies. At very high altitudes, 
where the quantity of oxygen in the air is greatly decreased, insufficient 
oxygen is transported to the tissues, and red cell production is greatly 
increased. In this case, it is not the concentration of red blood cells in the blood 
that controls red cell production but the amount of oxygen transported to the 
tissues in relation to tissue demand for oxygen. The principal stimulus for red 
blood cell production in low oxygen states is a circulating hormone called 
erythropoietin. In the absence of erythropoietin, hypoxia has little or no effect 
in stimulating red blood cell production. But when the erythropoietin system 
is functional, hypoxia causes a marked increase in erythropoietin production, 
and the erythropoietin in turn enhances red blood cell production until the 
hypoxia is relieved (Ganong, 1997; Hal, 2003; Guyton and Hall, 2006). 
The level of angiotensin II, on the other hand was not significantly 
varied (p>0.05), but the trend was to have higher levels of angiotensin II in 
Ajloun than the Sea level area. Angiotensin is an oligopeptide in the blood that 
causes vasoconstriction, increased blood pressure, and release of aldosterone 
from the adrenal cortex. It is derived from the precursor molecule 
angiotensinogen, a serum globulin produced in the liver and it plays an 
important role in the renin-angiotensin-aldosterone system. Angiotensin was 
independently isolated in Indianapolis and Argentina in the late 1930s (as 
'Angiotonin' and 'Hypertensin' respectively) and subsequently characterized 
and synthesized by groups at the Cleveland Clinic and Ciba laboratories in 
Basel, Switzerland (Basso and Terragno, 2001). 
We think that the effect of altitude in this study may work 
independently from angiotensin II and other mechanisms need to be further 
investigated. 
 
Conclusion: The findings of the present study showed that living in high 
altitudes is associated with the risk of developing hypertension and other 
related diseases. The angiotensin therapeutic options have to be taken in 
treating patients with hypertension in these areas.  
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